AstraZeneca Imfinzi combination fails advanced lung cancer study
The combination is also being tested in clinical trials for bladder, blood cancers
Author
GSK builds oncology pipeline as drug shown to help myeloma patients
Two doses of belantamab mafodotin helped subdue disease in adults who received three prior treatments for multiple myeloma
Roche taps Lilly executive Garraway as chief medical officer
Garraway, most recently Eli Lilly's senior vice president, oncology research and development and Lilly research laboratories novel…
AstraZeneca’s Farxiga meets main goal of heart failure study
Farxiga belongs to a class of medicines called SGLT2 inhibitors, which control blood sugar levels by causing the kidneys to expel…
US FDA pulls up Emcure Pharma for manufacturing violations at Pune plant
In the letter, the US FDA said inspectors during February 11-20 this year found significant deviations from standard manufacturing…
Roche’s personalised cancer treatment wins FDA approval
The treatment, Rozlytrek, is a tyrosine kinase inhibitor that targets patients who must be identified via genetic profiling
AstraZeneca’s Tagrisso helps lung cancer patients live longer: study
The British drugmaker announced overall positive survival results from the study in patients with epidermal growth factor…
Roche says Tecentriq prevents disease worsening or death in patients with advanced bladder cancer
Roche is evaluating treatment in combination with other medicines for early, advanced forms of disease
Sanofi and Regeneron get EU approval for Dupixent
European Commission has extended marketing authorisation for Dupixent European Union to include adolescents 12 to 17 years of age…
US FDA finds “significant violations” at India’s Strides plant
The drugmaker was caught trying to dispose quality-control records, the FDA said in a letter made public on July 16